In contrast to that in adenocarcinoma, it has been consistently reported that there is no association between PIK3CA mutation and PD-L1 expression in SCC, regardless of the specific cancer type [96, 102, 114, 115]. This evidence concerns the gene PIK3CA and adenocarcinoma.